Content about emergency treatment

January 29, 2013
Sanofi's Auvi-Q epinephrine injection now available

Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.

BRIDGEWATER, N.J. — Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.

 

May 14, 2012
Mylan marks Food Allergy Awareness Week

A company that makes an emergency treatment for severe allergic reactions is marking the 15th annual Food Allergy Awareness Week.

BASKING RIDGE, N.J. — A company that makes an emergency treatment for severe allergic reactions is marking the 15th annual Food Allergy Awareness Week.

Mylan Specialty, a division of drug maker Mylan, said it would support various initiatives to raise awareness of life-threatening food allergies during the special week, which started Sunday and ends Saturday. Mylan Specialty is the maker of EpiPen (epinephrine), used to treat anaphylaxis, a severe allergic reaction that can occur quickly and without warning.

April 27, 2012
Mylan, Pfizer, Teva reach deal over generic version of EpiPen

Two companies have settled with Teva over the latter's efforts to launch a generic version of an emergency treatment for allergic reactions.

NEW YORK — Two companies have settled with Teva over the latter's efforts to launch a generic version of an emergency treatment for allergic reactions.

Under the agreement, involving Mylan and Pfizer's Meridian Medical Technologies subsidiary, Teva will be allowed to launch a generic version of EpiPen (epinephrine) auto-injector in June 2015, assuming it wins approval from the Food and Drug Administration. Mylan Specialty markets the EpiPen, which Meridian manufactures.

August 2, 2011
FDA gives tentative approval to Intelliject device

The Food and Drug Administration has given tentative approval to an emergency treatment for severe allergic reactions made by Intelliject, the drug maker said.

RICHMOND, Va. — The Food and Drug Administration has given tentative approval to an emergency treatment for severe allergic reactions made by Intelliject, the drug maker said.

May 9, 2010
Study: Retail clinics save nonemergency patients money

Allergy sufferers can save money and receive quality, convenient care by skipping the emergency room...

INDIANAPOLIS Allergy sufferers can save money and receive quality, convenient care by skipping the emergency room and instead visiting a retail-based or urgent-care clinic, according to a recent study.

The study conducted by HealthCore, WellPoint’s outcomes research subsidiary, found that patients can save anywhere from $50 to $400 in out-of-pocket costs per visit by skipping the ER and heading to a retail health- or urgent-care clinic when they are unable to see their primary care physician.